Effects of quaternary ammonium compounds on the movement of potassium out of the cerebrospinal fluid.
D000818:Animals; D001692:Biological Transport / Q000187:drug effects*; D002415:Cats; D002794:Choline / Q000494:pharmacology; D003650:Decamethonium Compounds / Q000494:pharmacology; D005260:Female; D006584:Hexamethonium Compounds / Q000494:pharmacology; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009388:Neostigmine / Q000494:pharmacology; D009536:Niacinamide / Q000494:pharmacology; D010477:Perfusion; D010880:Piperidines / Q000494:pharmacology; D011188:Potassium / Q000134:cerebrospinal fluid*; D011194:Potassium Isotopes; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology*; D013390:Succinylcholine / Q000494:pharmacology; D013757:Tetraethylammonium Compounds / Q000494:pharmacology; D014403:Tubocurarine / Q000494:pharmacology
D003650:Decamethonium Compounds; D006584:Hexamethonium Compounds; D010880:Piperidines; D011194:Potassium Isotopes; D000644:Quaternary Ammonium Compounds; D013757:Tetraethylammonium Compounds; D009536:Niacinamide; D009388:Neostigmine; D013390:Succinylcholine; D002794:Choline; D011188:Potassium; D014403:Tubocurarine